Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Academy

Academy

Glenn Magerman, Professor - Mathias Dewatripont, Professor - Bram De Rock, Professor

ULB
" Learning from the curve is a voluntary and open source research project on COVID-19 and economics. It is a joint initiative of researchers in economics at ECARES, Solvay, ULB. Our mission is to provide detailed and real-time information and visualizations on COVID-19 and economics for the general public and the press, to serve as a platform for research collaboration on these topics, to understand the impact of COVID-19 on the economic tissue of countries and regions, to provide policy recommendations based on scientific arguments supported by data analytics. Learning from the curve started as a voluntary effort of faculty and students in empirical economics at ECARES. We are also very grateful for funding from the Special COVID-19 ULB grant. None of this would be possible without either. We call data from various sources, which are referenced in the respective dashboards and articles. We provide data sources and code on our Github organization. All publicly available data, code...

Jean-Noël Missa, Professor, FNRS Research Director

ULB - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The "Data against Corona task force" aim is to analyze data on the spread of the virus, making use of telecom- and epidemiological data. Based on this information the task force's goal is to: Take action in containing the rising number of infections, leveling the peak amount, and thus limiting the number of patients in hospital at the same time; Take measures to lower the infection curve; Provide a detailed assessment of the measures taken to contain the contagion. The role of the Ethics committee is to review the output of the "Data Against Corona" taskforce and to provide an ethical advice to the Steering Committee. The committee will highlight potential ethical conflicts arising from decisions taken based on the collection and analysis of the telecom and health data, such as : - Is the collection of information aligned with the concept of data protection ? - Are there potential & actual biases in the...

O. Vandenberg, Pr. - N. Clumeck, Pr. - C. Montesinos, Pr. - N. Dauby, MD, PhD - C. Gilles, MD - C. Martin, MD - S. Van den Wijngaert, MD - A. Marchant, Pr. - D. Martiny, Pr. - S. De Wit, Pr.

LHUB-ULB - Royal Academy of Medicine of Belgium
" "The purpose of this study is to map the healthcare workers exposure risk in Saint-Pierre University Hospital by combining molecular methods with serological assays. In summary, the short-term objective is threefold: (1) Provide an estimate of the sero-prevalence at baseline among high-risk health care workers (2) Determine prospectively the incidence of new SARS-CoV-2 infections among high-risk health care workers (3) Estimate the healthcare worker exposure to the virus by serological data to help our five partner hospitals in their day-to-day management of the ongoing pandemic The mid-term objectives are: (1) Establish an accurate mapping of the spread of the virus among our population allowing to identify the chain of transmission, (2) Identify predictive immunological markers of susceptibility to infection and disease severity to inform vaccine strategies and, (3) Establish solid diagnosis algorithm that will help adequate lockdown...

Ph. DELVENNE, FNRS Research Director / Chef de service Anatomie pathologique - J. GUIOT, Chef de clinique Pneumologie - L. RENAUD, Chef de service Pneumologie - M. MOUTSCHEN, Chef de service Infectiologie- B. MISSET, Chef de service Soins Intensifs

ULiège, CHU - Royal Academy of Medicine of Belgium
" Nous faisons face à une pandémie d'infection COVID-19. Ce virus pathogène est source de complications pulmonaires aggravant fortement le pronostic de nos patients. De nos jours, tant les mécanismes physiopathologiques en cause que les marqueurs de sévérité de l'atteinte restent indéterminés. Il apparaît donc comme urgent de pouvoir identifier des marqueurs diagnostiques, pronostiques et prédictifs pour nos patients. Dans ce contexte, plusieurs voies rapidement explorables nous apparaissent comme critiques. Le but final de cette étude est de contribuer à une prise en charge plus ciblée des patients porteurs d'une infection au SRAS-Cov-2. "
Funding: Fonds Léon Frederic
Publication References: Dix publications représentatives : 1) Prevention of murine radiogenic thymic lymphomas by tumor necrosis factor or by marrow grafting. HUMBLET C, GREIMERS R, DELVENNE P, DEMAN J, BONIVER J, DEFRESNE MP. J Natl Cancer Inst 88 (1996), 824-831. IF...

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Sandy Tubeuf, Professor - Dominique Vanpee, Professor

UCLouvain - Royal Academy of Medicine of Belgium
" TThe project US3R is a general population survey that will measure the magnitude of utilised, postponed and foregone medical care in relation with other health care needs than coronavirus symptoms during the confinement period in Belgium. The study aims to describe the magnitude of unsatisfied health care needs for various types of care. It will also identify the reasons for these postponed and foregone care according to gender, health status, geographical location and socioeconomic status. "
Funding: Budget Jeune Académique UCLouvain (Sandy Tubeuf)
Contact: Sandy Tubeuf, PhD Email: sandy.tubeuf@uclouvain.be
Comment: Voir: https://uclouvain.be/fr/decouvrir/presse/actualites/coronavirus-avez-vous-renonce-a-des-soins-medicaux.html Lien vers l'enquête : https://uclouvainph.qualtrics.com/jfe/form/SV_8D3WX8lH34Lf6LP

Souad Rahmouni, Doctor

GIGA-Institute, ULiège - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The main objective of our research program is the identification of human genetic factors impacting the COVID19 pandemic. Within the COVID-19 host genetics initiative (https://www.covid19hg.org/), we will establish a shared set of phenotypes to be combined with genomic data for standard GWAS and further meta-analysis. Field of expertise of our laboratory : genetics, genomics, bioinformatics, immune-response related diseases. In addition, the GIGA Institute is an interdisciplinary research institute from the ULiege devoted to academic excellence in the biomedical sciences to foster ground-breaking medical innovation. It comprises 583 members attached to six faculties (Medicine, Science, Veterinary Medicine, Engineering, Agbiotech, Psychology) that are organized in four disease-based (neuroscience, cancer, infection-inflammation-immunity, cardiovascular) and two method-based thematic units...

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19

AcceptRead more about cookies

Disclaimer - Terms and conditions of use


The purpose of the provisions below is to define the conditions under which the F.R.S.-FNRS gives you access to this website www.COVID19-WB.be.

1. Acceptance of the general conditions of use

The F.R.S.-FNRS gives you access to the www.COVID19-WB.be website and the information contained therein, you accept these conditions. The F.R.S.-FNRS may modify them at any time.

2. Use of the website

The content of this website is provided to you for general information purposes only. The content of this website may only be used in connection with the services offered on the website and for your personal use. This website may not be used as a basis for any evaluation of the F.R.S.-FNRS and may in no way bind or be opposable to the F.R.S.-FNRS. Nothing on the website can be considered as an offer to purchase or provide services or to conclude a contract.

The user undertakes to use the website in compliance with the laws and legal and/or contractual notices. The user may not use it in any way that would prejudice the interests of the F.R.S.-FNRS and/or its partners.

3. Guarantees and limitations of liability for the use of the website

In general, the F.R.S.-FNRS cannot, under any circumstances, be held liable for direct or indirect damage, or for any other damage of any nature whatsoever, resulting from the use of this website or from the impossibility of using it for any reason whatsoever, whether or not this liability is contractual, tortious or quasi-delictual, or whether it is based on no-fault liability or otherwise, and this even if the F.R.S.-FNRS is not liable for any damage resulting from the use of this website or from the impossibility of using it for any reason whatsoever, whether or not this liability is contractual, tortious or quasi-delictual, or whether it is based on no-fault liability or otherwise, and this even if the F.R.S.-FNRS is not liable for any damage resulting from the use of this website. FNRS would have been advised of the possibility of such damages.

3.1 Information

The information on this site is the exclusive responsibility of its authors. The F.R.S.-FNRS uses all reasonable means to publish on this website information which, to its knowledge, is up to date. However, it does not guarantee the adequacy, accuracy or exhaustiveness of such information nor does it guarantee that the website will always be complete and up to date in all respects. The information contained on this website may contain inaccuracies in content, technical inaccuracies or typing errors. This information is provided for information purposes only and is subject to periodic changes. The F.R.S.-FNRS may be required to make improvements and/or changes to this website at any time and without notice.

The use of this website, and consequently the information obtained, or elements downloaded when using the service, is the sole responsibility of the user. The F.R.S.-FNRS declines all responsibility for any damage that may result from the use of the information on this website.

The user also acknowledges that he or she shall be solely responsible for any damage to his or her computer system or any loss of data resulting from the downloading of any content.

3.2. Hypertext links

This website contains hypertext links to other sites as well as references to other sources of information, which are provided for your information only. The F.R.S.-FNRS does not control these sites and the information contained therein and therefore cannot offer any guarantee as to the quality and/or exhaustive nature of this information.

The F.R.S.-FNRS declines all responsibility for any unsuitable, illegitimate or illegal content present on the hyperlinks as well as for any damage that may result from consulting them.

3.3. Acts of Internet users

The F.R.S.-FNRS shall in no way be held responsible for the actions of Internet users.

4. Intellectual property rights

The trademarks on the site (www.COVID19-WB.be) may not be used in connection with any product or service other than those of the F.R.S.-FNRS, in any way that is likely to create confusion or in any way that would depreciate or discredit the F.R.S.-FNRS.

Unless explicitly authorized to do so, the user may not, under any circumstances, copy, reproduce, translate, represent, modify, transmit, publish, adapt, distribute, broadcast, license, transfer, sell, on any medium whatsoever, by any means whatsoever, or exploit in any way whatsoever, all or part of this website without the prior written authorization of the F.R.S.-FNRS. Any infringement may result in civil and criminal prosecution.

AcceptRead more about cookies